Impact of a Digital Diabetes Prevention Program on Risk Factors for Chronic Disease in a Workforce Cohort.


Journal

Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 16 10 2020
medline: 19 8 2021
entrez: 15 10 2020
Statut: ppublish

Résumé

Evaluate the effect of a digital Diabetes Prevention Program (dDPP) on chronic disease risk factors in a workplace population. dDPP participants were employees and spouses with BMI ≥ 24 kg/m and prediabetes or diabetes (n = 84). Annual change in risk factors before and after dDPP were assessed in the dDPP group and in a retrospectively identified matched control group drawn from those who participated in a dDPP after the conclusion of this study (n = 252). In the dDPP group, body weight, BMI, fasting glucose, triglycerides, total cholesterol and LDL-cholesterol decreased in the post-dDPP period compared with the pre-dDPP period (P < 0.05). In the control group, no difference between the annual change before and after dDPP was observed (P > 0.37). The dDPP was effective in reducing risk factors for chronic disease in a workplace setting.

Identifiants

pubmed: 33055524
doi: 10.1097/JOM.0000000000002044
pii: 00043764-202012000-00010
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1040-1045

Références

Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States. 2020. Atlanta, GA: US Department of Health and Human Services, 2020. Available at: https://www.cdc.gov/diabetes/library/features/diabetes-stat-report.html. Accessed July 1, 2020.
Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007; 78:305–312.
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393–403.
Knowler WC, Fowler SE, et al. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374:1677–1686.
Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015; 3:866–875.
Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012; 35:723–730.
Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med 2013; 44: (4 Suppl 4): S346–S351.
LeFevre ML, Force USPST. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014; 161:587–593.
Hafez D, Fedewa A, Moran M, O’Brien M, Ackermann R, Kullgren JT. Workplace interventions to prevent type 2 diabetes mellitus: a narrative review. Curr Diab Rep 2017; 17:9.
Kaspin LC, Gorman KM, Miller RM. Systematic review of employer-sponsored wellness strategies and their economic and health-related outcomes. Popul Health Manag 2013; 16:14–21.
Joiner KL, Nam S, Whittemore R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: a systematic review and meta-analysis. Prev Med 2017; 100:194–207.
Sepah SC, Jiang L, Ellis RJ, McDermott K, Peters AL. Engagement and outcomes in a digital DIABETES Prevention Program: 3-year update. BMJ Open Diabetes Res Care 2017; 5:e000422.
Wilson MG, Castro Sweet CM, Edge MD, et al. Evaluation of a Digital Behavioral Counseling Program for reducing risk factors for chronic disease in a workforce. J Occup Environ Med 2017; 59:e150–e155.
Hernan MA, Hernandez-Diaz S, Robbins JM. A structural approach to selection bias. Epidemiology 2004; 15:615–625.
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999; 22:623–634.
Sepah SC, Jiang L, Peters AL. Translating the Diabetes Prevention Program into an online social network: validation against CDC standards. Diabetes Educ 2014; 40:435–443.
Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: (25 Suppl 2): S1–S45.
Honaker J, King G, Blackwell M. Amelia II: a program for missing data. J Stat Softw 2011; 45:1–47.
Honaker J, King G. What to do about missing values in time series cross-section data. Am J Pol Sci 2010; 54:561–581.
Ho DE, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 2011; 42:42.
Rosenbaum PR, Rubin DB. Propensity scores: the central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41–55.
Mahalanobis PC. On the generalised distance in statistics. Proc Natl Inst Sci India 1936; 2:49–55.
Rubin DB. Multiple Imputation for Nonresponse in Surveys. Hoboken, NJ: John Wiley & Sons, Inc; 1987.
Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. In: 2018.
American Diabetes Association. 3. Prevention or delay of type 2 diabetes: standards of medical care in diabetes. Diabetes Care 2019; 42: (Suppl 1): S29–S33.
Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC's National Diabetes Prevention Program. Diabetes Care 2017; 40:1331–1341.
Salinardi TC, Batra P, Roberts SB, et al. Lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites. Am J Clin Nutr 2013; 97:667–676.
Centers for Disease Control and Prevention. Diabetes Prevention Recognition Program. Standards and Operating Procedures. Atlanta, GA: Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf (March 1, 2018). Accessed June 1, 2020.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42:878–884.
Kaufman HW, Williams FR, Odeh MA. Value of laboratory tests in employer-sponsored health risk assessments for newly identifying health conditions: analysis of 52,270 participants. PLoS One 2011; 6:e28201.

Auteurs

Charles E Birse (CE)

Quest Diagnostics (Dr Birse, Dr Shiffman, Ms Satish, Dr Fragala, Mr Arellano, Mr Lagier); Omada Health (Dr Sweet); UC San Diego, School of Medicine, San Diego, California (Ms Satish).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH